Clinical Trial Update: Evaluation of the Analgesic Effect of Intramyometrial Botulinum Toxin Injection Via Hysteroscopy in Severe Primary Dysmenorrhea [Phase 3]

View source ↗

Summary

This Clinical Trials entry describes a Phase 3 study evaluating the analgesic effect of intramyometrial botulinum toxin injection given during hysteroscopy in w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysmenorrhea
• Pelvic Pain

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Nantes University Hospital | Conditions: Primary Dysmenorrhea, Chronic Pelvic Pain | Phase 3 | Status: RECRUITING